Download PDF
Semin intervent Radiol 2024; 41(02): 144-153
DOI: 10.1055/s-0044-1787163
Review Article

Image-Guided Ablation of Renal Masses: Challenges to Produce High-Quality Evidence and Future Directions

Vinson Wai-Shun Chan
1   Faculty of Medicine and Health, Leeds Institute of Medical Research at St. James's University Hospital, University of Leeds, Leeds, United Kingdom
,
Helen Hoi-Lam Ng
1   Faculty of Medicine and Health, Leeds Institute of Medical Research at St. James's University Hospital, University of Leeds, Leeds, United Kingdom
2   Division of Diagnostic and Interventional Radiology, Institute of Oncology, St. James's University Hospital, Leeds, United Kingdom
,
Tze Min Wah
1   Faculty of Medicine and Health, Leeds Institute of Medical Research at St. James's University Hospital, University of Leeds, Leeds, United Kingdom
2   Division of Diagnostic and Interventional Radiology, Institute of Oncology, St. James's University Hospital, Leeds, United Kingdom
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Image-guided ablation (IGA) is a rapidly developing field in interventional oncology. There is some evidence suggesting IGA's non-inferiority compared with partial or radical nephrectomy for the treatment of small renal masses (SRM). However, these are mostly limited to retrospective cohort studies. This review article outlines the evidence comparing IGA to partial nephrectomy by collating the different survival measures and evaluates the challenges of producing clinical trials and high-quality evidence. The main challenges are due to the heterogeneity of SRM, patient selection bias, unstandardized endpoint and outcomes, and the lack of global practice standards. Despite the evidence thus far demonstrating that IGA stands as a non-inferior treatment modality for SRMs, exhibiting favorable short- and long-term outcomes, further robust research is needed to integrate ablation techniques into routine clinical practice with a multidisciplinary approach. There is emerging evidence that suggests randomized controlled trial in SRMs is possible, and technologies such as histotripsy as well as artificial intelligence are used in IGA.

Keywords

ablation - clinical trial - renal mass - renal cancer - interventional radiology


Publication History

Article published online:
10 July 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68 (06) 394-424
    CrossrefPubMedGoogle Scholar
  • 2 Warren H, Tran M. Incidental small renal tumours: are we performing unnecessary surgery?. Trends Urol Men's Health 2023; 14 (02) 11-14
    CrossrefPubMedGoogle Scholar
  • 3 Chan VW-S, Tan WS, Leow JJ. et al. Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic. World J Urol 2021; 39 (12) 4295-4303
    CrossrefPubMedGoogle Scholar
  • 4 Campbell SC, Uzzo RG, Karam JA, Chang SS, Clark PE, Souter L. Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA Guideline: Part II. J Urol 2021; 206 (02) 209-218
    CrossrefPubMedGoogle Scholar
  • 5 Chan VW-S, Abul A, Osman FH. et al. Ablative therapies versus partial nephrectomy for small renal masses - a systematic review and meta-analysis. Int J Surg 2022; 97: 106194
    CrossrefPubMedGoogle Scholar
  • 6 Lehrer R, Cornelis F, Bernhard J-C. et al. Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablation. Eur Radiol 2023; 33 (12) 8426-8435
    CrossrefPubMedGoogle Scholar
  • 7 Chan VW-S, Osman FH, Cartledge J. et al. Long-term outcomes of image-guided ablation and laparoscopic partial nephrectomy for T1 renal cell carcinoma. Eur Radiol 2022; 32 (09) 5811-5820
    CrossrefPubMedGoogle Scholar
  • 8 Xing M, Kokabi N, Zhang D, Ludwig JM, Kim HS. Comparative effectiveness of thermal ablation, surgical resection, and active surveillance for T1a renal cell carcinoma: a Surveillance, Epidemiology, and End Results (SEER)-Medicare-linked population study. Radiology 2018; 288 (01) 81-90
    CrossrefPubMedGoogle Scholar
  • 9 Andrews JR, Atwell T, Schmit G. et al. Oncologic outcomes following partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2019; 76 (02) 244-251
    CrossrefPubMedGoogle Scholar
  • 10 Yu J, Zhang X, Liu H. et al. Percutaneous microwave ablation versus laparoscopic partial nephrectomy for cT1a renal cell carcinoma: a propensity-matched cohort study of 1955 patients. Radiology 2020; 294 (03) 698-706
    CrossrefPubMedGoogle Scholar
  • 11 Park BK, Gong IH, Kang MY. et al. RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome. Eur Radiol 2018; 28 (07) 2979-2985
    CrossrefPubMedGoogle Scholar
  • 12 Chang X, Zhang F, Liu T. et al. Radio frequency ablation versus partial nephrectomy for clinical T1b renal cell carcinoma: long-term clinical and oncologic outcomes. J Urol 2015; 193 (02) 430-435
    CrossrefPubMedGoogle Scholar
  • 13 Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up. Eur Urol 2012; 61 (06) 1156-1161
    CrossrefPubMedGoogle Scholar
  • 14 Anglickis M, Anglickienė G, Andreikaitė G, Skrebūnas A. Microwave thermal ablation versus open partial nephrectomy for the treatment of small renal tumors in patients over 70 years old. Medicina (Kaunas) 2019; 55 (10) 664
    CrossrefPubMedGoogle Scholar
  • 15 Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179 (01) 75-79 , discussion 79–80
    CrossrefPubMedGoogle Scholar
  • 16 Neves JB, Warren H, Santiapillai J. et al. Nephron sparing treatment (NEST) for small renal masses: a feasibility cohort-embedded randomised controlled trial comparing percutaneous cryoablation and robot-assisted partial nephrectomy. Eur Urol 2024; 85 (04) 333-336
    CrossrefPubMedGoogle Scholar
  • 17 Takaki H, Yamakado K, Soga N. et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol 2010; 28 (06) 460-468
    CrossrefPubMedGoogle Scholar
  • 18 Kim JH, Li S, Khandwala Y, Chung KJ, Park HK, Chung BI. Association of prevalence of benign pathologic findings after partial nephrectomy with preoperative imaging patterns in the United States from 2007 to 2014. JAMA Surg 2019; 154 (03) 225-231
    CrossrefPubMedGoogle Scholar
  • 19 Chan VW-S, Keeley Jr FX, Lagerveld B. et al. The changing trends of image-guided biopsy of small renal masses before intervention-an analysis of European multinational prospective EuRECA registry. Eur Radiol 2022; 32 (07) 4667-4678
    CrossrefPubMedGoogle Scholar
  • 20 Richard PO, Jewett MA, Bhatt JR. et al. Renal tumor biopsy for small renal masses: a single-center 13-year experience. Eur Urol 2015; 68 (06) 1007-1013
    CrossrefPubMedGoogle Scholar
  • 21 Marconi L, Dabestani S, Lam TB. et al. Systematic review and meta-analysis of diagnostic accuracy of percutaneous renal tumour biopsy. Eur Urol 2016; 69 (04) 660-673
    CrossrefPubMedGoogle Scholar
  • 22 Widdershoven CV, Aarts BM, Zondervan PJ. et al. Renal biopsies performed before versus during ablation of T1 renal tumors: implications for prevention of overtreatment and follow-up. Abdom Radiol (NY) 2021; 46 (01) 373-379
    CrossrefPubMedGoogle Scholar
  • 23 Soomro N, Lecouturier J, Stocken DD. et al. Surveillance versus ablation for incidentally diagnosed small renal tumours: the SURAB feasibility RCT. Health Technol Assess 2017; 21 (81) 1-68
    CrossrefPubMedGoogle Scholar
  • 24 Georgiades CS, Rodriguez R, Littrup PJ. et al. Development of a research agenda for percutaneous renal tumor ablation: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol 2010; 21 (12) 1807-1816
    CrossrefPubMedGoogle Scholar
  • 25 Wah TM, Pech M, Thormann M. et al. A multi-centre, single arm, non-randomized, prospective European trial to evaluate the safety and efficacy of the HistoSonics System in the Treatment of Primary and Metastatic Liver Cancers (#HOPE4LIVER). Cardiovasc Intervent Radiol 2023; 46 (02) 259-267
    CrossrefPubMedGoogle Scholar
  • 26 HistoSonics Inc. The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy. Accessed May 8, 2024 at: https://classic.clinicaltrials.gov/show/NCT05432232
    PubMedGoogle Scholar
  • 27 Knott EA, Swietlik JF, Longo KC. et al. Robotically-assisted sonic therapy for renal ablation in a live porcine model: initial preclinical results. J Vasc Interv Radiol 2019; 30 (08) 1293-1302
    CrossrefPubMedGoogle Scholar
  • 28 Levy S, Goldberg SN, Roth I. et al. Clinical evaluation of a robotic system for precise CT-guided percutaneous procedures. Abdom Radiol (NY) 2021; 46 (10) 5007-5016
    CrossrefPubMedGoogle Scholar
  • 29 Amalou H, Wood BJ. Multimodality fusion with MRI, CT, and ultrasound contrast for ablation of renal cell carcinoma. Case Rep Urol 2012; 2012: 390912
    PubMedGoogle Scholar
  • 30 Lanza C, Carriero S, Biondetti P, Angileri SA, Carrafiello G, Ierardi AM. Advances in imaging guidance during percutaneous ablation of renal tumors. Semin Ultrasound CT MR 2023; 44 (03) 162-169
    CrossrefPubMedGoogle Scholar
  • 31 A study looking at 3 different treatments for kidney cancer (CONSERVE). Cancer Research UK. Accessed April 12, 2024 at: https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-looking-3-different-treatments-for-kidney-cancer-conserve#undefined
    PubMedGoogle Scholar
  • 32 Joana BN, David C, Lee G. et al. Protocol for a feasibility study of a cohort embedded randomised controlled trial comparing Nephron Sparing Treatment (NEST) for small renal masses. BMJ Open 2019; 9 (06) e030965
    CrossrefPubMedGoogle Scholar
  • 33 Nickolls BJ, Relton C, Hemkens L. et al. Randomised trials conducted using cohorts: a scoping review. BMJ Open 2024; 14 (03) e075601
    CrossrefPubMedGoogle Scholar
  • 34 Kitley W, Sulek J, Sundaram C, Bahler CD. Treatment trends and long-term survival associated with cryotherapy and partial nephrectomy for small renal masses in the National Cancer Database using propensity score matching. J Endourol 2019; 33 (05) 408-414 DOI: 10.1089/end.2018.0548.
    CrossrefPubMedGoogle Scholar
  • 35 Alam R, Patel HD, Osumah T. et al Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study. BJU Int 2019; 123 (01) 42-50 DOI: 10.1111/bju.14490.
    CrossrefPubMedGoogle Scholar
  • 36 Liu N, Huang D, Cheng X. et al Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype. Urol Oncol 2017; 35 (08) 530.e1-530.e6 DOI: 10.1016/j.urolonc.2017.03.014.
    CrossrefPubMedGoogle Scholar
  • 37 Larcher A, Sun M, Dell'Oglio P. et al Mortality, morbidity and healthcare expenditures after local tumour ablation or partial nephrectomy for T1A kidney cancer. Eur J Surg Oncol 2017; 43 (04) 815-822 DOI: 10.1016/j.ejso.2016.08.023.
    CrossrefPubMedGoogle Scholar
  • 38 Chehab M, Friedlander JA, Handel J. et al Percutaneous cryoablation vs. partial nephrectomy: cost comparison of T1a tumors. J Endourol 2016; 30 (02) 170-176 DOI: 10.1089/end.2015.0183.
    CrossrefPubMedGoogle Scholar
  • 39 Hruby G, Reisiger K, Venkatesh R, Yan Y, Landman J. Comparison of laparoscopic partial nephrectomy and laparoscopic cryoablation for renal hilar tumors. Urology 2006; 67 (01) 50-54 DOI: 10.1016/j.urology.2005.07.031.
    CrossrefPubMedGoogle Scholar
  • 40 Stern JM, Svatek R, Park S. et al Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 2007; 100 (02) 287-290 DOI: 10.1111/j.1464-410X.2007.06937.x.
    CrossrefPubMedGoogle Scholar